Verification of unmet medical needs in patients with juvenile idiopathic arthritis in Japan
Modern Rheumatology · 2025
DOI: 10.1093/mr/roaf032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Rheumatology, 2025. Verfasst von Masaki Shimizu und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Perinatal and Maternal Medicine, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo 113-8519…. Hauptthemen laut MEDLINE: Arthritis, Juvenile, Antirheumatic Agents, Antibodies, Monoclonal, Humanized, Health Services Needs and Demand. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
Objectives
To identify unmet medical needs (UMNs) of medical practices and investigate the real-world prescribing practices of therapeutic medical treatments and test implementation for patients with juvenile idiopathic arthritis (JIA).
Methods
The possible UMNs were collected from eight paediatric and eight adult rheumatologists. To verify UMNs, the real-world prescribing practices of therapeutic medical treatments and test implementation for patients with JIA were described using the National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB).
Results
Fifty-eight possible UMNs collected from 16 experts and 35 UMNs were investigated using NDB. The highest priority UMNs was the expansion of indications for subcutaneous tocilizumab (TCZ sc) and subcutaneous abatacept— subcutaneous tocilizumab was administered to 12.8% systemic JIA and 5.5% JIA with polyarthritis or oligoarthritis. Comorbidities for systemic JIA and JIA with polyarthritis or oligoarthritis included hypertension (7.1%, 1.3%), osteoporosis (17%, 5.4%), depression (2.3%, 1.3%), diabetes (1.9% systemic JIA), and iritis and/or uveitis (6.5% JIA with polyarthritis or oligoarthritis).
Conclusions
The highest priority UMNs for JIA was the expansion of indications for abatacept sc and especially subcutaneous tocilizumab. This study reveals the real-world prescribing practices of therapeutic medical treatments and test implementation for patients with JIA in Japan.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Perinatal and Maternal Medicine, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo 113-8519 Japan.
- Department of Rheumatology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
- Showa University Research Administration Center, Showa University, Tokyo, Japan.
- Department of Public Health and Epidemiology, Meiji Pharmaceutical University, Tokyo, Japan.
- Department of General Medical Science, Graduate School of Medicine, Chiba University, Chiba, Japan.
- Department of Allergy and Rheumatology, Chiba Children's Hospital, Chiba, Japan.
ORCID-Profile: Masaki Shimizu
Zitieren
APA
Shimizu, M., Inoue, E., Sakai, R., Inoue, Y., Mitsunaga, K., Sugihara, T., Hirano, T., Izawa, K., Kishida, D., Matsushita, M., Mori, M., Narazaki, H., Nishikomori, R., Sumitomo, S., Tanaka, T., Yamazaki, S., Yamaji, K., Yokogawa, N., Yoshifuji, H., & Miyamae, T. (2025). Verification of unmet medical needs in patients with juvenile idiopathic arthritis in Japan. Modern Rheumatology. https://doi.org/10.1093/mr/roaf032
Vancouver
Shimizu M, Inoue E, Sakai R, Inoue Y, Mitsunaga K, Sugihara T, et al. Verification of unmet medical needs in patients with juvenile idiopathic arthritis in Japan. Modern Rheumatology. 2025. doi:10.1093/mr/roaf032
BibTeX
@article{Shimizu2025,
author = {Shimizu, Masaki and Inoue, Eisuke and Sakai, Ryoko and Inoue, Yuzaburo and Mitsunaga, Kanako and Sugihara, Takahiko and Hirano, Toru and Izawa, Kazushi and Kishida, Dai and Matsushita, Masakazu and Mori, Masaaki and Narazaki, Hidehiko and Nishikomori, Ryuta and Sumitomo, Shuji and Tanaka, Takayuki and Yamazaki, Susumu and Yamaji, Ken and Yokogawa, Naoto and Yoshifuji, Hajime and Miyamae, Takako},
title = {Verification of unmet medical needs in patients with juvenile idiopathic arthritis in Japan},
journal = {Modern Rheumatology},
year = {2025},
doi = {10.1093/mr/roaf032}
}
EUVIMED